Novelos Claims Securities Action Strikes Out
Novelos Therapeutics Inc. argued Friday that a putative class of investors alleging the company misled them about the prospects of a developmental-stage cancer drug had failed for a third time to...To view the full article, register now.
Already a subscriber? Click here to view full article